Silvio Antonio Garcia, MD | |
901 45th St, Kaplan Cancer Center, West Palm Beach, FL 33407-2413 | |
(561) 881-2815 | |
(561) 881-0951 |
Full Name | Silvio Antonio Garcia |
---|---|
Gender | Male |
Speciality | Radiation Oncology |
Experience | 44 Years |
Location | 901 45th St, West Palm Beach, Florida |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1821074030 | NPI | - | NPPES |
379583700 | Medicaid | FL |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
2085R0001X | Radiology - Radiation Oncology | ME51412 (Florida) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Jfk Medical Center | Atlantis, FL | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Comprehensive Radiation Oncology, Llc | 4688913494 | 2 |
News Archive
Men 45 years or older who received pneumococcal vaccine were not less likely to have a heart attack or stroke compared to men who did not receive the vaccine, according to a study in the May 5 issue of JAMA.
Researchers at the Pitié Salpêtrière Hospital, Department of Virology, Paris, France determined that in BNT162b2-vaccinated participants who received two doses, their sera harbored at least a neutralizing titer against the three SARS-CoV-2 variants.
BeiGene (Beijing), Co., Ltd., an innovative oncology company focused on developing targeted and immune-oncology therapeutics, today announced the achievement of a clinical milestone in the company's collaboration with Merck Serono, the biopharmaceutical division of Merck, Darmstadt, Germany, for BGB-283, a second-generation BRAF inhibitor candidate currently in Phase 1 development.
A clinical trial of a new Ebola vaccine (ChAd3-EBO-Z) that resulted from an unprecedented global consortium assembled at the behest of the World Health Organization has found that it is well tolerated and stimulates strong immune responses in adults in Mali, West Africa and in the US, according to a study published in the latest issue of the journal Lancet Infectious Disease.
› Verified 5 days ago
Entity Name | Jfk Internal Medicine Faculty Practice, Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1467614651 PECOS PAC ID: 9830254671 Enrollment ID: O20090211000623 |
News Archive
Men 45 years or older who received pneumococcal vaccine were not less likely to have a heart attack or stroke compared to men who did not receive the vaccine, according to a study in the May 5 issue of JAMA.
Researchers at the Pitié Salpêtrière Hospital, Department of Virology, Paris, France determined that in BNT162b2-vaccinated participants who received two doses, their sera harbored at least a neutralizing titer against the three SARS-CoV-2 variants.
BeiGene (Beijing), Co., Ltd., an innovative oncology company focused on developing targeted and immune-oncology therapeutics, today announced the achievement of a clinical milestone in the company's collaboration with Merck Serono, the biopharmaceutical division of Merck, Darmstadt, Germany, for BGB-283, a second-generation BRAF inhibitor candidate currently in Phase 1 development.
A clinical trial of a new Ebola vaccine (ChAd3-EBO-Z) that resulted from an unprecedented global consortium assembled at the behest of the World Health Organization has found that it is well tolerated and stimulates strong immune responses in adults in Mali, West Africa and in the US, according to a study published in the latest issue of the journal Lancet Infectious Disease.
› Verified 5 days ago
Entity Name | Comprehensive Radiation Oncology, Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1306338090 PECOS PAC ID: 4688913494 Enrollment ID: O20190221002678 |
News Archive
Men 45 years or older who received pneumococcal vaccine were not less likely to have a heart attack or stroke compared to men who did not receive the vaccine, according to a study in the May 5 issue of JAMA.
Researchers at the Pitié Salpêtrière Hospital, Department of Virology, Paris, France determined that in BNT162b2-vaccinated participants who received two doses, their sera harbored at least a neutralizing titer against the three SARS-CoV-2 variants.
BeiGene (Beijing), Co., Ltd., an innovative oncology company focused on developing targeted and immune-oncology therapeutics, today announced the achievement of a clinical milestone in the company's collaboration with Merck Serono, the biopharmaceutical division of Merck, Darmstadt, Germany, for BGB-283, a second-generation BRAF inhibitor candidate currently in Phase 1 development.
A clinical trial of a new Ebola vaccine (ChAd3-EBO-Z) that resulted from an unprecedented global consortium assembled at the behest of the World Health Organization has found that it is well tolerated and stimulates strong immune responses in adults in Mali, West Africa and in the US, according to a study published in the latest issue of the journal Lancet Infectious Disease.
› Verified 5 days ago
Mailing Address | Practice Location Address |
---|---|
Silvio Antonio Garcia, MD 812 Harbour Isle Ct, West Palm Beach, FL 33410-4417 Ph: (561) 512-5445 | Silvio Antonio Garcia, MD 901 45th St, Kaplan Cancer Center, West Palm Beach, FL 33407-2413 Ph: (561) 881-2815 |
News Archive
Men 45 years or older who received pneumococcal vaccine were not less likely to have a heart attack or stroke compared to men who did not receive the vaccine, according to a study in the May 5 issue of JAMA.
Researchers at the Pitié Salpêtrière Hospital, Department of Virology, Paris, France determined that in BNT162b2-vaccinated participants who received two doses, their sera harbored at least a neutralizing titer against the three SARS-CoV-2 variants.
BeiGene (Beijing), Co., Ltd., an innovative oncology company focused on developing targeted and immune-oncology therapeutics, today announced the achievement of a clinical milestone in the company's collaboration with Merck Serono, the biopharmaceutical division of Merck, Darmstadt, Germany, for BGB-283, a second-generation BRAF inhibitor candidate currently in Phase 1 development.
A clinical trial of a new Ebola vaccine (ChAd3-EBO-Z) that resulted from an unprecedented global consortium assembled at the behest of the World Health Organization has found that it is well tolerated and stimulates strong immune responses in adults in Mali, West Africa and in the US, according to a study published in the latest issue of the journal Lancet Infectious Disease.
› Verified 5 days ago
Nikhil Ramaiya, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 1309 N Flagler Dr, West Palm Beach, FL 33401 Phone: 561-366-4100 Fax: 866-326-5063 | |
Dr. Teresa M Cortinas, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 5405 Okeechobee Blvd, West Palm Beach, FL 33417 Phone: 561-697-3001 Fax: 561-697-3284 | |
Dr. Mohamad Ali Saghir, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 1210 Lake Ave, West Palm Beach, FL 33401 Phone: 313-310-2070 | |
Dr. Ciro Anthony Adamo, MD Radiology Medicare: Medicare Enrolled Practice Location: 5601 Corporate Way Ste 307, West Palm Beach, FL 33407 Phone: 561-686-0506 Fax: 561-687-5601 | |
Dr. Paola Devis, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: Va Medical Center, Imaging Service (115), 7305 N Military Trail, West Palm Beach, FL 33401 Phone: 561-422-6770 | |
Dr. Theodore Poritz, M.D. Radiology Medicare: Medicare Enrolled Practice Location: 6086 Wildcat Run, West Palm Beach, FL 33412 Phone: 561-624-3980 | |
Meir Seggev, M.D. Radiology Medicare: Not Enrolled in Medicare Practice Location: 1967 Brandywine Rd, Apt 301, West Palm Beach, FL 33409 Phone: 561-688-0802 |